Clinical Trial Update: Efficacy Study of a Preseasonal Treatment With AllerT in Subjects With Birch Pollen Allergy [Phase 2]

View source ↗

Summary

Phase 2 efficacy results update for preseasonal AllerT treatment in individuals with birch pollen–related allergic rhinitis and rhinoconjunctivitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis
• Allergic Rhinoconjunctivitis

Drugs mentioned

• AllerT

Snippet

Sponsor: Anergis | Conditions: Allergic Rhinitis, Rhinoconjunctivitis | Phase 2 | Status: COMPLETED | Results posted: 2015-04-13